Taiga BioActives Inc. Achieves Key Commercial Milestone

Taiga BioActives Inc. | Aug 06, 2008

Calgary based Taiga BioActives Inc. today announced the debut of its newly branded product line, Dr. Krane’s KoolLips™ Cold Sore Treatment in leading retail pharmacies in Canada, achieving a significant milestone in the Company’s evolution. For the first time, KoolLips™ is available in stores across Western Canada and coming soon to retail chains in central and eastern Canada.

“We are very pleased to be able to offer KoolLips™ more broadly to consumers and expect to see widespread retail coverage of Canada before the end of the year”, says John Hiebert, President and CEO of Taiga BioActives Inc. “Initial response from retailers has been strong, demonstrating a high level of confidence that the new brand can compete in the mainstream cold sore segment based on its efficacy and targeted consumer appeal”, adds Hiebert.

Tech Avenue Ventures principal Nancy Markley commented that Taiga has reached a significant corporate milestone and is well positioned with the addition of its new brand and network of retail agents to gain a foothold in two key market segments, the natural health and mainstream retail markets, across Canada. “We expect continued success from Taiga as it expands distribution of KoolLips™ and looks to development of next generation geranium-based products”.

Dr Krane’s KoolLips™ Cold Sore Treatment is now available at all London Drugs Stores in British Columbia, Alberta, Saskatchewan and Manitoba, Super Drug Mart stores in Alberta and will soon be available at Brunet (Quebec) and other Drug and Food Chains across Canada.

About Taiga BioActives Inc.

Taiga Bioactives Inc., headquartered in Calgary, Alberta, Canada, is a specialty natural products company, marketing branded consumer products with functional plant-derived active ingredients. Taiga is committed to developing high performance natural treatment options for a range of oral and skin care applications in personal care, over-the-counter and prescriptions markets. These products will be marketed in retail channels through Taiga BioActives Inc. in association with leading distributors across Canada. More information can be accessed at www.taigabioactives.com

Tech Avenue Ventures and Taiga BioActives formed a strategic partnership in 2007 to facilitate the commercialization of its branded line of topical skincare products, and execute its strategy to build an integrated specialty natural products company. Tech Avenue Ventures Corp, incorporated in December 2005 and based in Calgary, Alberta, is a venture development company focused on accelerating the commercialization of high value consumer and medical products. Tech Avenue Ventures is leveraging its life sciences management and core expertise in technology development and commercialization to guide the development process and build profitable companies. More information can be accessed at www.taventures.ca.